Analysts at Jefferies say the cannabis industry could reach $130 billion by 2029. “This assumes full U.S. federal legalization, full recreational and medical legalization across Europe, full medical and recreational legalization across Lat Am, and cannabis disruption of a number of other industries,” noted the analysts, as quoted by Yahoo Finance. “Industries at risk of disruption are pharma, alcohol, health and wellness, pet care and smoking cessation.” In addition, according to Arcview Market Research and BDS Analytics, global spending on cannabis could reach $57 billion by 2027. All as people around the world wake up to the health benefits of cannabis, including the treatment of insomnia, stress, anxiety, pain, and even chronic issues. That’s opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), Canopy Growth Corporation (TO:WEED)(NYSE:CGC), Aurora Cannabis Inc. (NYSE:ACB)(TO:ACB), Charlotte’s Web Holdings Inc. (CN:CWEB) (OTC:CBWHF), Aphria Inc. (NYSE:APHA)(TO:APHA), and Green Growth Brands Inc. (CSE:GGB)(OTC:GGBXF).